MOBIFLEX TAB 20MG DIN 00884367
Health Canada record
| Active ingredient(s) | TENOXICAM 20 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01AC02 TENOXICAM |
| Original market date | 31-Dec-1991 |
| Current status date | 19-Jul-2001 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TENOXICAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02230510 | TENOXICAM | APOTEX INC | Tablet | TENOXICAM 20 MG | Approved |
| 02231314 | NOVO-TENOXICAM TAB 20MG | NOVOPHARM LIMITED | Tablet | TENOXICAM 20 MG | Cancelled Post Market |
| 02230661 | TENOXICAM | AA PHARMA INC | Tablet | TENOXICAM 20 MG | Dormant |
| 02231120 | TENOXICAM-20 | PRO DOC LIMITEE | Tablet | TENOXICAM 20 MG | Cancelled Post Market |
International API supply for TENOXICAM
1 valid EDQM Certificates of Suitability from 1 holders.
Request a quote for MOBIFLEX TAB 20MG